Cargando…
A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology
The objective was to determine the prognostic utility of a new biomarker combination in prostate cancer (PCa) patients undergoing Radical Prostatectomy (RP). Serum samples and clinical data of 557 men who underwent RP for PCa with pathological stage (pT) <3 at Martini Clinic (Hamburg, Germany) we...
Autores principales: | Athanasiou, Alcibiade, Tennstedt, Pierre, Wittig, Anja, Huber, Ramy, Straub, Oliver, Schiess, Ralph, Steuber, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589165/ https://www.ncbi.nlm.nih.gov/pubmed/34767586 http://dx.doi.org/10.1371/journal.pone.0259093 |
Ejemplares similares
-
Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies
por: Steuber, Thomas, et al.
Publicado: (2018) -
Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer
por: Macagno, Annalisa, et al.
Publicado: (2020) -
Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer
por: Endt, Kathrin, et al.
Publicado: (2017) -
The quintet
por: Hancock, Herbie, 1940-, et al.
Publicado: (1988) -
Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer
por: Goetze, Sandra, et al.
Publicado: (2022)